Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Paliperidone“
Suchtreffer
Begriffe & Kennungen
Byannli (previously Paliperidone Janssen-Cilag International) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenByannli (previously Paliperidone Janssen-Cilag International) · 4.8 · Reporting suspected adverse reactions after authorisation of the medical product is important. It allows conti
Eintrag öffnenByannli (previously Paliperidone Janssen-Cilag International) · 4.8 · Summary of the safety profile
Eintrag öffnenByannli (previously Paliperidone Janssen-Cilag International) · 4.8 · System Organ Adverse reactions Class Frequency Very Common Uncommon Rare Not knowna common Infections and uppe
Eintrag öffnenByannli (previously Paliperidone Janssen-Cilag International) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenByannli (previously Paliperidone Janssen-Cilag International) · 4.8 · The following are all adverse reactions that were reported with paliperidone by frequency category estimated f
Eintrag öffnenByannli (previously Paliperidone Janssen-Cilag International) · 4.8 · The most frequently observed adverse reactions reported in ≥ 5% of patients in the randomised double-blind act
Eintrag öffnenByannli (previously Paliperidone Janssen-Cilag International) · 4.8 · Undesirable effects noted with risperidone formulations
Eintrag öffnenInvega · 4.5 · Caution is advised if paliperidone is combined with other medicines known to lower the seizure threshold (i.e.
Eintrag öffnenInvega · 4.5 · Given the primary CNS effects of paliperidone (see section 4.8), INVEGA should be used with caution in combina
Eintrag öffnenInvega · 4.5 · Medicinal products affecting gastrointestinal transit time may affect the absorption of paliperidone, e.g., me
Eintrag öffnenInvega · 4.5 · Paliperidone may antagonise the effect of levodopa and other dopamine agonists. If this combination is deemed
Eintrag öffnenInvega · 4.5 · Potential for INVEGA to affect other medicines Paliperidone is not expected to cause clinically important phar
Eintrag öffnenInvega · 4.8 · Paliperidone is the active metabolite of risperidone. The safety profile of risperidone may be pertinent.
Eintrag öffnenInvega · 4.8 · Undesirable effects noted with risperidone formulations Paliperidone is the active metabolite of risperidone,
Eintrag öffnenOkedi · 4.5 · Paliperidone Concomitant use of OKEDI with paliperidone is not recommended as paliperidone is the active metab
Eintrag öffnenPaliperidon Palmitat
Eintrag öffnenTrevicta (previously Paliperidone Janssen)
Eintrag öffnenTrevicta (previously Paliperidone Janssen) · 4.1 Therapeutic indications · 1
Eintrag öffnenTrevicta (previously Paliperidone Janssen) · 4.3 Contraindications · 1
Eintrag öffnen